Frédéric Triebel

Overview

Best Publications

• LAG-3, a novel lymphocyte activation gene closely related to CD4.

  F Triebel;S Jitsukawa;E Baixeras;S Roman-Roman

  1042
  Citations

• Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer

  Nicolas Giraldo;Nicolas Giraldo;Nicolas Giraldo;Etienne Becht;Etienne Becht;Etienne Becht;Franck Pages;Georgios P Skliris

  538
  Citations

• CD4/major histocompatibility complex class II interaction analyzed with CD4‐ and lymphocyte activation gene‐3 (LAG‐3)‐Ig fusion proteins

  Bertrand Huard;Philippe Prigent;Muriel Tournier;Denis Bruniquel

  492
  Citations

• Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

  E Baixeras;B Huard;C Miossec;S Jitsukawa

  467
  Citations

• Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.

  Bertrand Huard;Renato Mastrangeli;Philippe Prigent;Denis Bruniquel

  405
  Citations

• LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

  Chiara Camisaschi;Chiara Casati;Francesca Rini;Michela Perego

  402
  Citations

• Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes

  Bertrand Huard;Muriel Tournier;Thierry Hercend;Frédéric Triebel

  337
  Citations

• First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

  Chrystelle Brignone;Maya Gutierrez;Fawzia Mefti;Etienne Brain

  331
  Citations

• A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma

  Chrystelle Brignone;Bernard Escudier;Caroline Grygar;Manon Marcu

  325
  Citations

• MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis

  Patrice Hemon;Francette Jean-Louis;Kiran Ramgolam;Chrystelle Brignone

  312
  Citations

• CD3/TCR Complex-Associated Lymphocyte Activation Gene-3 Molecules Inhibit CD3/TCR Signaling

  Sigrid Hannier;Muriel Tournier;Georges Bismuth;Frédéric Triebel

  307
  Citations

• The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells

  Laëtitia Maçon-Lemaître;Frédéric Triebel

  288
  Citations

• Cellular expression and tissue distribution of the human LAG-3-encoded protein, an MHC class II ligand.

  B. Huard;P. Gaulard;F. Faure;T. Hercend

  280
  Citations

• Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).

  Susanne Andreae;Fabienne Piras;Nicolas Burdin;Frédéric Triebel

  256
  Citations

• A gamma-chain complex forms a functional receptor on cloned human lymphocytes with natural killer-like activity.

  P. Moingeon;S. Jitsukawa;F. Faure;F. Troalen

  249
  Citations

• Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.

  Simone A. Joosten;Krista E. van Meijgaarden;Nigel D. L. Savage;Tjitske de Boer

  238
  Citations

• LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination

  Frédéric Triebel

  229
  Citations

• Direct evidence to support the immunosurveillance concept in a human regressive melanoma.

  A Mackensen;G Carcelain;S Viel;M C Raynal

  224
  Citations

• MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).

  Susanne Andreae;Sandrine Buisson;Frédéric Triebel

  220
  Citations

• A unique V-J-C-rearranged gene encodes a gamma protein expressed on the majority of CD3+ T cell receptor-alpha/beta- circulating lymphocytes.

  Frederic Triebel;Florence Faure;Marita Graziani;Setsuko Jitsukawa

  211
  Citations